2025 annual financial data

Arcturus Therapeutics Holdings 2025 Net margin

Direct answer

Net margin was -97.86%.

Operating income was -74,955,000 USD and net income was -65,783,000 USD.
Operating cash flow was -74,271,000 USD.

Get free Arcturus Therapeutics Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
67,221,000 USD
Operating income
-74,955,000 USD
Net income
-65,783,000 USD
Operating cash flow
-74,271,000 USD